Live tape
Top 8, mentions 7d30,017NVDA14,564 mentions▲ +0.04ANT4,160 mentions▲ +0.06GOOGL2,936 mentions▲ +0.04SPY2,248 mentions▲ +0.05QQQ1,804 mentions▲ +0.04SPCX1,748 mentions▲ +0.08AMD1,367 mentions▲ +0.06AAPL1,190 mentions▲ +0.04

Equity · Healthcare

MRVI

NASDAQ

Maravai LifeSciences Holdings (MRVI)

7.65 USD +3.80% vs prior close Sep 24, 2026
Maravai LifeSciences Holdings, Inc. price graph
23 sessions
10 6 24 Aug 24 Sep

The line runs 8.41 USD on 24 August through 7.65 USD on 24 September, on a scale from 6 to 10. Days the market did not trade hold the previous close, flat.

Market cap
1.1B USD
Revenue, year to Dec 2025
185.7M USD
EPS, diluted, year to Dec 2025
−0.90 USD
52-week range
2.69 USD – 9 USD
Avg volume
308.8K

as of Sep 24, 2026

Have Maravai LifeSciences Holdings (MRVI) insiders bought or sold shares recently?

In the 90 days to 22 Nov 2026, no Maravai LifeSciences Holdings insider bought or sold shares on the open market; all 6 Form 4 filings in that window were grants, exercises, tax withholding or transfers (SEC Form 4).

Form 4, 90 days to 22 Nov 2026, newest Form 4 filing 9 Nov 2026

0buys
0sells
6other filings
Have Maravai LifeSciences Holdings (MRVI) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
09 Nov 2026Brust BerndChief Executive OfficerTax withheld29,250220K USD
30 Oct 2026Asarpota RajeshChief Financial OfficerTax withheld5,46646K USD
08 Oct 2026Brust BerndChief Executive OfficerTax withheld29,250217K USD
30 Sep 2026Asarpota RajeshChief Financial OfficerTax withheld5,46542K USD
08 Sep 2026Brust BerndChief Executive OfficerTax withheld29,250214K USD
31 Aug 2026Asarpota RajeshChief Financial OfficerTax withheld5,46542K USD

Which funds hold Maravai LifeSciences Holdings (MRVI)?

8 of the 45 institutional funds we track reported a Maravai LifeSciences Holdings position for the quarter ended 30 Sep 2026 — a combined 163.5M USD; the latest of those filings landed 16 Nov 2026.

Form 13F

Which funds hold Maravai LifeSciences Holdings (MRVI)?
FundPositionSharesValueShares q/q
Millennium ManagementHeld (±25%)7,622,15058.4M USD+17.1%
Renaissance TechnologiesHeld (±25%)3,987,88930.5M USD−13.4%
Point72 Asset ManagementAdded2,514,69619.3M USD+25.4%
Two Sigma InvestmentsHeld (±25%)2,196,58916.8M USD−2.6%
Marshall WaceAdded2,034,07015.6M USD+38.2%
Citadel AdvisorsHeld (±25%)1,857,84114.2M USD−12.5%
Tudor Investment CorpTrimmed1,029,5367.9M USD−44.3%
AQR Capital ManagementHeld (±25%)101,821780K USD+20.0%
Man GroupExited

Have members of Congress traded Maravai LifeSciences Holdings (MRVI)?

The most recent congressional trade disclosed in Maravai LifeSciences Holdings is a sale by Daniel S. Goldman (house, NY), dated 10 Apr 2023.

STOCK Act disclosures

Have members of Congress traded Maravai LifeSciences Holdings (MRVI)?
TradedMemberTypeAmountFiled after
10 Apr 2023Daniel S. Goldmanhouse · Democrat–NYSale1K USD–15K USD39 days

What has been filed or recorded for Maravai LifeSciences Holdings (MRVI)?

The filings we hold for Maravai LifeSciences Holdings, newest first: 7 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 30 Oct 2026. No next earnings date is announced in SEC filings yet.

What has been filed or recorded for Maravai LifeSciences Holdings (MRVI)?
And
30 Oct 2026Fails to deliverShares failed to deliver87 shares736 USD notional · <0.001% of shares out
29 Oct 2026Fails to deliverShares failed to deliver87,000 shares740K USD notional · 0.059% of shares out
28 Oct 2026Fails to deliverShares failed to deliver87,000 shares719K USD notional · 0.059% of shares out
23 Oct 2026Fails to deliverShares failed to deliver446 shares3K USD notional · <0.001% of shares out
14 Oct 2026Fails to deliverShares failed to deliver104,952 shares685K USD notional · 0.071% of shares out
13 Oct 2026Fails to deliverShares failed to deliver4 shares28 USD notional · <0.001% of shares out
08 Oct 2026Fails to deliverShares failed to deliver2,087 shares16K USD notional · 0.001% of shares out
30 Sep 2026Quarterly earningsQ3 2026 reportedEPS −0.09 USDRevenue $46M
30 Sep 2026FinancialsTotal assets600.1M USDat period end
30 Sep 2026FinancialsTotal equity195.9M USDat period end
30 Jun 2026Quarterly earningsQ2 2026 reportedEPS −0.08 USDRevenue $51M
31 Mar 2026Quarterly earningsQ1 2026 reportedEPS −0.02 USDRevenue $66M
31 Dec 2025Annual reportFY 2025 reportedEPS −0.90 USDRevenue $186M
31 Dec 2025FinancialsRevenue185.7M USDfiscal year
31 Dec 2025FinancialsNet income−130.8M USDfiscal year
31 Dec 2025FinancialsDiluted EPS−0.90 USDfiscal year
30 Sep 2025Quarterly earningsQ3 2025 reportedEPS −0.18 USDRevenue $42M
30 Jun 2025Quarterly earningsQ2 2025 reportedEPS −0.27 USDRevenue $47M
31 Mar 2025Quarterly earningsQ1 2025 reportedEPS −0.21 USDRevenue $47M
31 Dec 2024Annual reportFY 2024 reportedEPS −1.05 USDRevenue $259M

What do people ask about Maravai LifeSciences Holdings (MRVI)?

From live data
What did Maravai LifeSciences Holdings shares close at?7.65

Maravai LifeSciences Holdings closed at 7.65 USD on 24 Sep 2026, up 3.80% on the close before. That is the end-of-day price from Finazon, not a live quote.

What is Maravai LifeSciences Holdings’ market cap?1.1B

Maravai LifeSciences Holdings is worth 1.1B USD by market value as of 24 Sep 2026, which is the share price times the shares on issue from its SEC filings.

What is Maravai LifeSciences Holdings’ revenue?185.7M

Maravai LifeSciences Holdings reported revenue of 185.7M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings

Have Maravai LifeSciences Holdings insiders bought or sold shares recently?6 filings

In the 90 days to 22 Nov 2026, no Maravai LifeSciences Holdings insider bought or sold shares on the open market; all 6 Form 4 filings in that window were grants, exercises, tax withholding or transfers (SEC Form 4). See Insiders

Which funds own Maravai LifeSciences Holdings?8 of 45

8 of the 45 funds we track reported a Maravai LifeSciences Holdings position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported positions were Millennium Management, Renaissance Technologies and Point72 Asset Management. See Funds

Have members of Congress traded Maravai LifeSciences Holdings?1 trade

Yes. 1 trade in Maravai LifeSciences Holdings appears in the congressional disclosures we hold: a sale by Daniel S. Goldman (House, NY) dated 10 Apr 2023, filed 19 May 2023. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress

When did Maravai LifeSciences Holdings last report earnings?−0.09

Maravai LifeSciences Holdings last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of −0.09 USD; no next date is announced in SEC filings yet. See Filings

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARForm 4 filings (insider transactions)
  4. SEC EDGAR13F filings
  5. Wikimedia CommonsPortraits via Wikimedia Commons. Daniel S. Goldman: US House, Public domain.
  6. House disclosuresU.S. House of Representatives financial disclosures
  7. SECSEC fails-to-deliver (CNS) data
  8. SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
  9. SEC EDGARreported earnings figures and scheduled report dates
  10. SEC EDGARValuation computed from SEC EDGAR filings
  11. SEC filingAbout text: the company's latest annual report filed with the SEC (Business section), summarised in our own words